|Bid Price||-||Offer Price||-|
|Mid Price||GBX 88.04||Day Change||GBX +0.60 (0.69%)|
|Price Date||20 Oct 2017||Crown Rating|
|Shares Class||Inc.||Yield||2.60 %|
|Total Expense Ratio||0.00||Fund Size||27,300,000.00|
|Launch Date||01/07/2002||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.75||Sector||IMA UK Equity Income|
|Min Investment (£)||1,000.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00B806NQ09||Min TopUp (£)||500.00|
This Fund aims to achieve long-term capital growth through active management of a diversified portfolio invested primarily in UK equities.
Steve Magill is a Senior Portfolio Manager with a focus on UK Value Equity strategies. He joined UBS Global Asset Management in 1986, originally as an investment assistant. He took a career break between 1990 and 1993 to study, returning as a UK Equity Portfolio Manager. In 2000, Steve became a Pan-European pharmaceutical research analyst, taking on the role of Deputy Head of European Research in 2007. During this period Steve also co-ordinated the Global Healthcare team. He took on his current role in 2009. Steve is a Regular Member of the CFA Society of the UK and the CFA Institute.